Pharmacotherapeutic Potential of Bitter Gourd (Momordica charantia) in Age-related Neurological Diseases
Journal of Integrative Neuroscience · 23.04.2024 · 23 (4)
DOI: 10.31083/j.jin2304086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 23.04.2024. Verfasst von Seyed Mohammad Hosein Hosseini Adarmanabadi und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Sciences, 19839-63113 Tehran, Iran. Hauptthemen laut MEDLINE: Momordica charantia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Due to the growth of the elderly population, age-related neurological disorders are an increasing problem. Aging begins very gradually and later leads to several neurological issues such as lower neurotransmitter levels, oxidative stress, neuronal inflammation, and continual neuronal loss. These changes might contribute to brain disorders such as Alzheimer’s disease (AD), dementia or mild cognitive impairment, and epilepsy and glioma, and can also aggravate these disorders if they were previously present. Momordica charantia (bitter gourd), a member of the Cucurbitaceae family, is a good source of carbohydrates, proteins, vitamins, and minerals. It is used for diabetes and known for its hypoglycemic and antioxidant effects. In this review, we discuss the pharmaceutical effects of M. charantia on age-related neurological disorders. We searched several databases, including PubMed and Google Scholar, using MeSH terms. We searched articles published up until 2022 regardless of publication language. M. charantia is rich in luteolin, which increases acetylcholine in neurons by binding to enzymes in acetylcholine metabolism pathways, including butyrylcholinesterase and acetylcholinesterase. This binding inhibits the hyperphosphorylation of tau protein by restraining its kinase enzyme. Furthermore, this substance can lower serum cholesterol and has multi-target activity in AD and memory loss. M. charantia can also improve memory by decreasing tau protein and it also has potent antioxidant activity and anti-inflammatory effects. This review highlights that M. charantia has effects on many age-related neurological disorders, and can be a cost-effective supplement with minimal side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Shahid Beheshti University of Medical Sciences, 19839-63113 Tehran, Iran.
- Department of Food Science and Technology, University of Tehran, 14155-6619 Tehran, Iran.
- Student Research Committee, University of Social Welfare and Rehabilitation Sciences, 1985713871 Tehran, Iran.
- Student Research Committee, Vita-Salute San Raffaele University, 20132 Milan, Italy.
- Student Research Committee, Shahroud University of Medical Sciences, 3614773955 Shahroud, Iran.
- Student Research Committee, Mashhad University of Medical Sciences, 91778 99191 Mashhad, Iran.
Zitieren
APA
Adarmanabadi, S. M. H. H., Abadi, O. J. K., Amiri, A., Tamannaeifar, R., Balanian, S., Rasekhjam, M., Samiazar, M. S., Hasanpour, S., Peiravi, S., Alijanzadeh, D., Poudineh, M., Amiri, H., Mazhari, S. A., Khademi, R., Deravi, N., & Fathi, M. (2024). Pharmacotherapeutic Potential of Bitter Gourd (Momordica charantia) in Age-related Neurological Diseases. Journal of Integrative Neuroscience, 23(4). https://doi.org/10.31083/j.jin2304086
Vancouver
Adarmanabadi SMHH, Abadi OJK, Amiri A, Tamannaeifar R, Balanian S, Rasekhjam M, et al. Pharmacotherapeutic Potential of Bitter Gourd (Momordica charantia) in Age-related Neurological Diseases. Journal of Integrative Neuroscience. 2024;23(4). doi:10.31083/j.jin2304086
BibTeX
@article{Adarmanabadi2024,
author = {Adarmanabadi, Seyed Mohammad Hosein Hosseini and Abadi, Orod Jalali Khalil and Amiri, Amirhossein and Tamannaeifar, Rozhina and Balanian, Sahar and Rasekhjam, Mehdi and Samiazar, Mohammad Sadra and Hasanpour, Sara and Peiravi, Samira and Alijanzadeh, Dorsa and Poudineh, Mohadeseh and Amiri, Hamidreza and Mazhari, Seyed Amirhossein and Khademi, Reza and Deravi, Niloofar and Fathi, Mobina},
title = {Pharmacotherapeutic Potential of Bitter Gourd (Momordica charantia) in Age-related Neurological Diseases},
journal = {Journal of Integrative Neuroscience},
year = {2024},
volume = {23},
number = {4},
doi = {10.31083/j.jin2304086}
}
EUVIMED